https://www.selleckchem.com/pr....oducts/telacebec-q20
Preterm infants with severe bronchopulmonary dysplasia require rescue therapy with glucocorticoids, and hydrocortisone is increasingly replacing dexamethasone. The standard for rescue therapy is unclear. To quantify the short-term effects of respiratory rescue hydrocortisone of 4mg/kg/day for 3days. Retrospective single-center study. Ventilator-dependent infants born at 28weeks of gestation with an increased oxygen demand to maintain the target oxygen saturation at 88% to 95% 1week after birth. Ventilator settings, SpO /F